Seroprevalance of toxocara antibodies in multiple sclerosis and ankylosing spondylitis [2]

dc.contributor.authorKuk, Salih
dc.contributor.authorOzgocmen, Salih
dc.contributor.authorBulut, Serpil
dc.date.accessioned2026-08-12T16:10:10Z
dc.date.issued2006
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.4103/0019-5359.26605
dc.identifier.endpage299
dc.identifier.issn0019-5359
dc.identifier.issue7
dc.identifier.pmid16864915
dc.identifier.scopus2-s2.0-33746688535
dc.identifier.scopusqualityN/A
dc.identifier.startpage297
dc.identifier.urihttps://doi.org/10.4103/0019-5359.26605
dc.identifier.urihttps://hdl.handle.net/11508/41789
dc.identifier.volume60
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMedknow Publications and Media Pvt. Ltd
dc.relation.ispartofIndian Journal of Medical Sciences
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20260511
dc.subjectHLA B27 antigen; protozoon antibody; adult; ankylosing spondylitis; autoimmune disease; central nervous system; clinical article; confidence interval; controlled study; demography; female; human; letter; male; medical research; multiple sclerosis; seroprevalence; Toxocara; Toxocara canis; toxocariasis
dc.titleSeroprevalance of toxocara antibodies in multiple sclerosis and ankylosing spondylitis [2]
dc.typeLetter

Dosyalar